ChaseAJ, Fretz EB,WarburtonWP, et al.Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019 25. 612. Bakhai A, Collinson J, Flather MD, et al. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Int J Cardiol. 2005;100:79 84. 613. Groot MW, Head SJ, Bogers AJ, et al. Coronary revascularization in diabetic patients. A focus on the 3-year SYNTAX trial outcomes. Herz. 2012;37:281 6. 614. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percu- taneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55:432 40. 615. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multives- sel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575 81. 616. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for mul- tivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375 84. 617. Feit F, Manoukian SV, Ebrahimi R, et al. Safety and efficacy of bivali- rudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from theACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2008;51:1645 52. 618. Wiviott SD, Braunwald E, Angiolillo DJ, et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic out- comes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation. 